A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation: Irreversible Electroporation

Authors

  • Jacob Lavee
  • Gary Onik
  • Paul Mikus
  • Boris Rubinsky

DOI:

https://doi.org/10.1532/HSF98.20061202

Abstract

Conclusions. We propose a new modality to perform atrial ablations, which holds the potential of providing very swift, precise, and complete transmurality with no local heating effects.

References

Abreu Filho CA, Lisboa LA, Dallan LA, et al. 2005. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation 112(suppl 9):I20-5.nAccord RE, van Suylen RJ, van Brakel TJ, Maessen JG. 2005. Postmortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fibrillation. Ann Thorac Surg 80:881-7.nBarnett SD, Ad N. 2006. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg 131:1029-35.nCoster HG. 1965. Quantitative analysis of the voltage-current relationship of fixed charge membranes and the associated property of "punch-through". Biophys J 5:669-86.nCrowley JM. 1973. Electrical breakdown of biomolecular lipid membranes as an electromechanical instability. Biophys J 13:711-24.nCummings JE, Pacifico A, Drago JL, Kilicaslan F, Natale A. 2005. Alternative energy sources for the ablation of arrhythmias. Pacing Clin Electrophysiol 28:434-43.nDavalos RV, Mir LM, Rubinsky B. 2005. Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223-31.nDeneke T, Khargi K, Muller KM, et al. 2005. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J 26:1797-803.nDoll N, Borger MA, Fabricius A, et al. 2003. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg 125:836-42.nEdd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. 2006. In-vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409-15.nFayad G, Modine T, Le Tourneau T, et al. 2003. Circumflex artery stenosis induced by intraoperative radiofrequency ablation. Ann Thorac Surg 76:1291-3.nGaynor SL, Byrd GD, Diodato MD, et al. 2006. Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. Ann Thorac Surg 81:72-6.nGehl J. 2003. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177:437-47.nMack CA, Milla F, Ko W, et al. 2005. Surgical treatment of atrial fibrillation using argon-based cryoablation during concomitant cardiac procedures. Circulation 112(suppl 9):I1-6.nManasse E, Medici D, Ghiselli S, Ornaghi D, Gallotti R. 2003. Left main coronary arterial lesion after microwave epicardial ablation. Ann Thorac Surg 76:276-7.nMelby SJ, Zierer A, Bailey MS, et al. 2006. A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 244:583-92.nMilla F, Skubas N, Briggs WM, et al. 2006. Epicardial beating heart cryoablation using a novel argon-based cryoclamp and linear probe. J Thorac Cardiovasc Surg 131:403-11.nMiller L, Leor J, Rubinsky B. 2005. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699-705.nMir LM, Belehradek M, Domenge C, et al. 1991. Electrochemotherapy, a novel antitumor treatment: first clinical trial. C R Acad Sci III 313:613-8.nNeumann E, Rosenheck K. 1972. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10:279-90.nNeumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. 1982. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841-5.nNinet J, Roques X, Seitelberger R, et al. 2005. Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. J Thorac Cardiovasc Surg 130:803-9.nRowan NJ, MacGregor SJ, Anderson JG, Fouracre RA, Farish O. 2000. Pulsed electric field inactivation of diarrhoeagenic Bacillus cereus through irreversible electroporation. Lett Appl Microbiol 31:110-4.nSantiago T, Melo J, Gouveia RH, et al. 2003. Epicardial radiofrequency applications: in vitro and in vivo studies on human atrial myocardium. Eur J Cardiothorac Surg 24:481-6.nThomas SP, Guy DJ, Boyd AC, et al. 2003. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg 75:543-8.nvan Brakel TJ, Bolotin G, Salleng KJ, et al. 2004. Evaluation of epicardial microwave ablation lesions: histology versus electrophysiology. Ann Thorac Surg 78:1397-402.nViola N, Williams MR, Oz MC, Ad N. 2002. The technology in use for the surgical ablation of atrial fibrillation. Semin Thorac Cardiovasc Surg 14:198-205.nWeaver JC. 2000. Electroporation of cells and tissues. IEEE Trans Plasma Sci 28:24-33.n

Published

2007-03-12

How to Cite

Lavee, J., Onik, G., Mikus, P., & Rubinsky, B. (2007). A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation: Irreversible Electroporation. The Heart Surgery Forum, 10(2), E162-E167. https://doi.org/10.1532/HSF98.20061202

Issue

Section

Article